指南与共识技术与安全胸部腹部CTMRUSDR

机会性筛查:放射学科学专家小组

Opportunistic Screening: Radiology Scientific Expert Panel.
PubMed 文献 · Radiology · 2023-05-23

放射学检查常包含与临床指征无关的丰富影像数据,机会性筛查即系统利用这些偶然发现。专家小组指出,体部CT结合人工智能可定量评估骨、肌肉、脂肪和血管钙化等组织成分,辅助风险分层和发现无症状疾病,但推广需放射科医生、转诊医生和患者接受,并需标准化采集与报告、扩展规范性数据,同时面临监管和报销障碍。

要点

  • 体部CT是机会性筛查的理想高容量模态,AI可自动定量骨、肌肉、脂肪和血管钙化。
  • 机会性CT筛查推广需放射科医生、转诊医生和患者接受,并标准化采集与报告。
  • 需按年龄、性别、种族和民族扩展规范性数据,监管和报销障碍构成挑战。

核心结论

  • 机会性CT筛查通过AI定量组织成分可提供风险分层并发现无症状疾病,若证明改善人群健康结局和成本效益,对支付方和医疗系统有吸引力,并可能最终支持独立的「有意识」CT筛查。

研究设计与样本

  • 放射学科学专家小组(Radiology Scientific Expert Panel)就机会性筛查进行的专家小组论述,未报告系统检索方法、证据分级或样本量。

关键影像表现/征象

  • 体部CT可定量评估骨、肌肉、脂肪和血管钙化等组织成分,提供风险分层并帮助检测无症状的临床前疾病。
  • 机会性筛查可应用于传统X线摄影、超声和MRI,但迄今多数关注集中于体部CT结合AI辅助方法。

临床应用与阅片要点

  • 机会性CT筛查的广泛实施需要放射科医生、转诊医生和患者接受。
  • 需标准化采集和报告措施,并按年龄、性别、种族和民族扩展规范性数据。
  • 监管和报销障碍并非不可逾越,但对商业化和临床使用构成重大挑战。

局限性

  • 机会性CT筛查广泛实施的潜在障碍包括需要放射科医生、转诊医生和患者的接受。
  • 需要标准化采集和报告措施,并按年龄、性别、种族和民族扩展规范性数据。
  • 监管和报销障碍对商业化和临床使用构成重大挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Radiologic tests often contain rich imaging data not relevant to the clinical indication. Opportunistic screening refers to the practice of systematically leveraging these incidental imaging findings. Although opportunistic screening can apply to imaging modalities such as conventional radiography, US, and MRI, most attention to date has focused on body CT by using artificial intelligence (AI)-assisted methods. Body CT represents an ideal high-volume modality whereby a quantitative assessment of tissue composition (eg, bone, muscle, fat, and vascular calcium) can provide valuable risk stratification and help detect unsuspected presymptomatic disease. The emergence of "explainable" AI algorithms that fully automate these measurements could eventually lead to their routine clinical use. Potential barriers to widespread implementation of opportunistic CT screening include the need for buy-in from radiologists, referring providers, and patients. Standardization of acquiring and reporting measures is needed, in addition to expanded normative data according to age, sex, and race and ethnicity. Regulatory and reimbursement hurdles are not insurmountable but pose substantial challenges to commercialization and clinical use. Through demonstration of improved population health outcomes and cost-effectiveness, these opportunistic CT-based measures should be attractive to both payers and health care systems as value-based reimbursement models mature. If highly successful, opportunistic screening could eventually justify a practice of standalone "intended" CT screening.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Pickhardt, Summers, Garrett, et al. Opportunistic Screening: Radiology Scientific Expert Panel. Radiology. 2023. PMID: 37219444. doi:10.1148/radiol.222044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。